GSK Investigational Site

Birmingham, Warwickshire B9 5SS

0 studies enrolling now · 4 studies all time

What they study most

HIV Infection, Infection, Human Immunodeficiency Virus I, Neoplasms, Prostate

Studies at this site

• A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily — Completed
• GW873140 In Combination With Kaletra In HIV Infected Subjects — Stopped early
• GW873140 In Combination With Combivir In HIV Infected Subjects — Stopped early
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed